Literature DB >> 17065646

A reversal of misfortune for myotonic dystrophy?

Thomas A Cooper1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17065646     DOI: 10.1056/NEJMcibr064708

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  8 in total

Review 1.  Cardiac involvement in patients with muscular dystrophies: magnetic resonance imaging phenotype and genotypic considerations.

Authors:  David Verhaert; Kathryn Richards; Jill A Rafael-Fortney; Subha V Raman
Journal:  Circ Cardiovasc Imaging       Date:  2011-01       Impact factor: 7.792

2.  Investigating the binding mode of an inhibitor of the MBNL1·RNA complex in myotonic dystrophy type 1 (DM1) leads to the unexpected discovery of a DNA-selective binder.

Authors:  Chun-Ho Wong; Stacie L Richardson; Yen-Jun Ho; Alex M H Lucas; Tiziano Tuccinardi; Anne M Baranger; Steven C Zimmerman
Journal:  Chembiochem       Date:  2012-10-24       Impact factor: 3.164

3.  A novel CUG(exp)·MBNL1 inhibitor with therapeutic potential for myotonic dystrophy type 1.

Authors:  Amin Haghighat Jahromi; Lien Nguyen; Yuan Fu; Kali A Miller; Anne M Baranger; Steven C Zimmerman
Journal:  ACS Chem Biol       Date:  2013-03-20       Impact factor: 5.100

4.  Localized co-transcriptional recruitment of the multifunctional RNA-binding protein CELF1 by lampbrush chromosome transcription units.

Authors:  Garry T Morgan
Journal:  Chromosome Res       Date:  2007-12-21       Impact factor: 5.239

Review 5.  Progress toward therapy with antisense-mediated splicing modulation.

Authors:  Liutao Du; Richard A Gatti
Journal:  Curr Opin Mol Ther       Date:  2009-04

6.  Selective inhibition of MBNL1-CCUG interaction by small molecules toward potential therapeutic agents for myotonic dystrophy type 2 (DM2).

Authors:  Chun-Ho Wong; Yuan Fu; Sreenivasa Rao Ramisetty; Anne M Baranger; Steven C Zimmerman
Journal:  Nucleic Acids Res       Date:  2011-07-18       Impact factor: 16.971

Review 7.  A journey in bioinspired supramolecular chemistry: from molecular tweezers to small molecules that target myotonic dystrophy.

Authors:  Steven C Zimmerman
Journal:  Beilstein J Org Chem       Date:  2016-01-25       Impact factor: 2.883

8.  Developing bivalent ligands to target CUG triplet repeats, the causative agent of myotonic dystrophy type 1.

Authors:  Yuan Fu; Kali A Miller; Lien Nguyen; Amin Haghighat Jahromi; Long M Luu; Anne M Baranger; Steven C Zimmerman
Journal:  J Med Chem       Date:  2013-11-21       Impact factor: 7.446

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.